Buyback yield (TTM)
0.13%
Shareholder yield (TTM)
0.13%
5Y share count change
29.3%
Buyback spend (TTM)
$1.54M
Cumulative buybacks
$6.98M
Key takeaways
- Aehr Test Systems (AEHR) repurchased about $1.54M of stock over the trailing twelve months.
- Diluted share count is up 29.3% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 0.22× — repurchases only partially offset SBC dilution.
- Cash buyback spend has compounded at +139.3% per year over the latest 5-year window.
Dividend & buyback yield over time for Aehr Test Systems (AEHR)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Aehr Test Systems (AEHR)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Aehr Test Systems (AEHR)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Aehr Test Systems (AEHR)
Latest: $784.00K
Overview
In 2025, Aehr Test Systems (AEHR) buyback spend totalled $784.00K – plunged 50.9% year-over-year.
Through 2020–2025 (5 years), Aehr Test Systems buyback spend delivered a +139.3% annualised rate; with mixed annual results across the window.
Aehr Test Systems buyback spend peaked at $2.06M in 2023; the latest annual figure is $784.00K in 2025 (61.9% below peak).
2023 marks the peak buyback spend at $2.06M, with the historical low of $0.00 recorded in 2004.
Aehr Test Systems Buyback Spend 2025: $784.00K
2025's buyback spend for Aehr Test Systems came in at $784.00K, plunged 50.9% below 2024.
Aehr Test Systems Buyback Spend 2024: $1.60M
Aehr Test Systems posted buyback spend of $1.60M in 2024, declined 22.5% below 2023.
Aehr Test Systems Buyback Spend 2023: $2.06M
In 2023, Aehr Test Systems reported buyback spend of $2.06M, surged 380.2% from 2022. This figure represents the highest annual value in the available history.
Aehr Test Systems Buyback Spend 2022: $429.00K
Aehr Test Systems buyback spend in 2022 was $429.00K, surged 2045.0% from 2021.
Aehr Test Systems Buyback Spend 2021: $20.00K
Aehr Test Systems buyback spend in 2021 was $20.00K.
See more financial history for Aehr Test Systems (AEHR).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $784.00K | $5.16M | −$4.38M | 0.28% | 0.03B | -0.1% | |
| 2024 | $1.60M | $2.52M | −$922.00K | 0.48% | 0.03B | +1.4% | |
| 2023 | $2.06M | $0.00 | $2.06M | 0.22% | 0.03B | +5.2% | |
| 2022 | $429.00K | $3.01M | −$2.58M | 0.19% | 0.03B | +18.4% | |
| 2021 | $20.00K | $0.00 | $20.00K | 0.03% | 0.02B | +2.5% | |
| 2020 | $10.00K | $910.00K | −$900.00K | 0.03% | 0.02B | +2.2% | |
| 2019 | $0.00 | $905.00K | −$905.00K | — | 0.02B | -1.7% | |
| 2018 | $0.00 | $996.00K | −$996.00K | — | 0.02B | +40.1% | |
| 2017 | $0.00 | $999.00K | −$999.00K | — | 0.02B | +35.0% | |
| 2016 | $0.00 | $1.02M | −$1.02M | — | — | — | |
| 2015 | $0.00 | $997.00K | −$997.00K | — | 0.01B | +1.3% | |
| 2014 | $0.00 | $829.00K | −$829.00K | — | 0.01B | +24.5% | |
| 2013 | $0.00 | $601.00K | −$601.00K | — | 0.01B | +5.9% | |
| 2012 | $0.00 | $709.00K | −$709.00K | — | 0.01B | +2.7% | |
| 2011 | $0.00 | $0.00 | $0.00 | — | 0.01B | +2.5% | |
| 2010 | $0.00 | $1.73M | −$1.73M | — | 0.01B | +1.5% | |
| 2009 | $0.00 | $1.27M | −$1.27M | — | 0.01B | -0.8% | |
| 2008 | $0.00 | $0.00 | $0.00 | — | 0.01B | +3.4% | |
| 2007 | $0.00 | $0.00 | $0.00 | — | 0.01B | +8.2% | |
| 2006 | $0.00 | $0.00 | $0.00 | — | 0.01B | +2.5% | |
| 2005 | $0.00 | $0.00 | $0.00 | — | 0.01B | +2.4% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.01B | +1.2% | |
| 2003 | $182.00K | $0.00 | $182.00K | 0.89% | 0.01B | +0.1% | |
| 2002 | $141.00K | $0.00 | $141.00K | 0.33% | 0.01B | -0.4% | |
| 2001 | $468.00K | $0.00 | $468.00K | 1.64% | 0.01B | +5.4% | |
| 2000 | $136.00K | $0.00 | $136.00K | — | 0.01B | -0.6% | |
| 1999 | $1.15M | $0.00 | $1.15M | — | 0.01B | +1.4% | |
| 1998 | $1.00K | $0.00 | $1.00K | — | 0.01B | +50.2% | |
| 1997 | $9.00K | $0.00 | $9.00K | — | 0.00B | — |
- 2025$784.00K
- 2024$1.60M
- 2023$2.06M
- 2022$429.00K
- 2021$20.00K
- 2020$10.00K
- 2019$0.00
- 2018$0.00
- 2017$0.00
- 2016$0.00
- 2015$0.00
- 2014$0.00
- 2013$0.00
- 2012$0.00
- 2011$0.00
- 2010$0.00
- 2009$0.00
- 2008$0.00
- 2007$0.00
- 2006$0.00
- 2005$0.00
- 2004$0.00
- 2003$182.00K
- 2002$141.00K
- 2001$468.00K
- 2000$136.00K
- 1999$1.15M
- 1998$1.00K
- 1997$9.00K
Buybacks vs stock-based compensation for Aehr Test Systems (AEHR)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.22×.
Buybacks vs dividends (share of cash returned) for Aehr Test Systems (AEHR)
How Aehr Test Systems splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Aehr Test Systems, ranked by their latest buyback spend.
| $90.71B | |
| $40.09B | |
| $18.42B | |
| $6.65B | |
| $6.31B | |
| $1.32B | |
| $0.00 | |
| $0.00 |
- $90.71B
- $40.09B
- $18.42B
- $6.65B
- $6.31B
- $1.32B
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $0.00 (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation